Today news
About the same in other media
BioNTech says it could tweak Covid vaccine in 100 days if needed
Reading now: 633
BioNTech says it could produce and ship an updated version of its vaccine within 100 days if the new Covid variant detected in southern Africa is found to evade existing immunity.
The biotechnology company is already investigating whether the vaccine it developed with Pfizer works well against the variant, named Omicron, which has caused concern due to its high number of mutations and initial suggestions that it could be transmitting more quickly.
The company says it will know in two weeks whether its current vaccine is likely to be sufficiently effective against the B.1.1.529 variant, based on lab-based experiments.
If required, BioNTech said it is poised to tweak its vaccine to match it more closely to the new variant.
“Pfizer and BioNTech
Read more on theguardian.comAbout this in other media
Tesco ad featuring Santa with Covid vaccine passport cleared by watchdog theguardian.com /3 years ago
UK ministers secure 114m more Covid vaccines for next two years theguardian.com /3 years ago
Teesside factory making Covid vaccine gets £400m injection theguardian.com /3 years ago
Show more
The website finance-news.co is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
